N95 face masks
N95 Face Masks On Sale as Low as $2.50/mask
N95 respirator masks are recommended as the preferred PPE mask for healthcare environments. A limited supply of this mask has been imported to help meet those needs. It is FDA registered as an N95 respirator mask and testing certification has been stamped on the FDA certificate below. We suggest anyone purchasing PPE read and review all the documentation associated with the product prior to making their selection. Foreign manufacturers of PPE products have had to comply with recent foreign regulations for box labeling in order to export these types of products. These regulations do not necessarily align with FDA regulations or allow the manufacturer to represent the product accurately on their product label. Therefore, we have supplied US regulations and classification documents below for this product, as they reside with the FDA.
FDA Registration No 3009608361
Shelf Life of 3 Years
Sealed Packs of 5 Masks Per Box
N95 respirator masks
Product Specifications / Dimensions
Bacterial Filtration Efficiency (BFE) | Greater than or equal to 95% |
---|---|
Filters Particles From Sizes | 0.3 – 2.5 microns |
Materials | 44% non-woven fabric, 28% melt-blown fabric, 28% hot air cotton |
Packaging | 5 pcs per sanitary sealed package |
Abstract
BACKGROUND: The N95 filtering facepiece respirator (FFR) is the most popular individual protective device to reduce exposure to particulate matter. However, concerns have been raised with regard to its use because it can increase respiratory resistance and dead space. Therefore, this study assessed the safety of N95 use in patients with COPD and air-flow limitation.
METHODS: This prospective study was performed at a tertiary hospital and enrolled 97 subjects with COPD. The subjects were monitored for symptoms and physiologic variables during a 10-min rest period and 6-min walking test while wearing an N95.
RESULTS: Of the 97 subjects, 7 with COPD did not wear the N95 for the entire test duration. This mask-failure group showed higher British modified Medical Research Council dyspnea scale scores and lower FEV1 percent of predicted values than did the successful mask use group. A modified Medical Research Council dyspnea scale score ≥ 3 (odds ratio 167, 95% CI 8.4 to >999.9; P = .008) or a FEV1 < 30% predicted (odds ratio 163, 95% CI 7.4 to >999.9; P = .001) was associated with a risk of failure to wear the N95. Breathing frequency, blood oxygen saturation, and exhaled carbon dioxide levels also showed significant differences before and after N95 use. N95 respirator masks
CONCLUSIONS: This study demonstrated that subjects with COPD who had modified Medical Research Council dyspnea scale scores ≥ 3 or FEV1 < 30% predicted wear N95s only with care
Reviews
There are no reviews yet.